(VIANEWS) – The NASDAQ opens in less than one hour and Alnylam Pharmaceuticals‘s pre-market value is already 6.95% up.

The last session, NASDAQ Composite ended with Alnylam Pharmaceuticals (ALNY) dropping 0.12% to $172.73. NASDAQ Composite fell 0.33% to $15,921.57, following the last session’s downward trend on what was a somewhat down trend trading session.


Today’s last reported volume for Alnylam Pharmaceuticals is 471166, 18.13% below its average volume of 575545.

Alnylam Pharmaceuticals’s last close was $172.73, 18.52% below its 52-week high of $212.00.

Alnylam Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth grew by 112.1%, now sitting on 687.53M for the twelve trailing months.


Alnylam Pharmaceuticals’s last day, last week, and last month’s current intraday variation average was 0.12%, 0.98%, and 2.72%, respectively.

Alnylam Pharmaceuticals’s highest amplitude of average volatility was 3.70% (day), 3.57% (last week), and 4.26% (last month), respectively.

More news about Alnylam Pharmaceuticals (ALNY).


Please enter your comment!
Please enter your name here